Dissolved and financials
CVR: 38027794
Previous names: CiVi Biopharma A/S
DKK 610,531
Gross profit
Net result: DKK -1,410,204
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Founded 20 September 2016
CVR · view overview
1 employee
CVR · 2018
Director role ended: Signe Melhedegård Hansen
CVR · 05/02/2026
View the full event history
CiVi Biopharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CiVi Biopharma A/S. The company has 1 employee (2018). In 2024, the company reported a gross profit of DKK 610,531 and a net result of DKK -1,410,204 compared with DKK -1,887,334 the year before. Equity in the 2024 report amounted to DKK 77,815.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | 611 t. | -1.4 mio. | 128 t. | 78 t. | 1 | |
| 202301/01/2023 – 31/12/2023 | 3.5 mio. | -1.9 mio. | 2.3 mio. | 1.5 mio. | 1 | |
| 202201/01/2022 – 31/12/2022 | 3.5 mio. | 326 t. | 3.9 mio. | 3.4 mio. | 1 | |
| 202101/01/2021 – 31/12/2021 | 4 mio. | 344 t. | 4.3 mio. | 3 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | 4.5 mio. | 392 t. | 4.1 mio. | 2.7 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | 7.2 mio. | 649 t. | 4.6 mio. | 2.3 mio. | 1 | |
| 201801/01/2018 – 31/12/2018 | 6 mio. | 707 t. | 7 mio. | 1.7 mio. | 1 |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. CiVi Biopharma ApS is registered in the Danish CVR register with the status Dissolved.
The CVR number of CiVi Biopharma ApS is 38027794.
In 2024, CiVi Biopharma ApS reported a gross profit of DKK 610,531.
CiVi Biopharma ApS had 1 employee in 2018 according to the Danish CVR register.
CiVi Biopharma ApS was founded on 20 September 2016.
CiVi Biopharma ApS was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
CiVi Biopharma ApS was dissolved on March 5, 2026.
As of February 5, 2026, REVISIONSFIRMAET EDELBO & LUND-LARSEN, STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of CiVi Biopharma ApS.
As of February 5, 2026, Signe Melhedegård Hansen has stepped down as liquidator of CiVi Biopharma ApS.
On February 5, 2026, CiVi Biopharma ApS exited liquidation.
CiVi Biopharma ApS has published its annual report for 2024. Gross profit came to DKK 610,531, and the net result was DKK -1,410,204.
As of October 30, 2025, Signe Melhedegård Hansen has stepped down as liquidator of CiVi Biopharma ApS.
On October 30, 2025, CiVi Biopharma ApS exited liquidation.
As of October 17, 2025, REVISIONSFIRMAET EDELBO & LUND-LARSEN, STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of CiVi Biopharma ApS.
As of October 17, 2025, Signe Melhedegård Hansen is registered as liquidator of CiVi Biopharma ApS.
As of October 17, 2025, Signe Melhedegård Hansen is registered as liquidator of CiVi Biopharma ApS.
On October 17, 2025, the company changed its name from CiVi Biopharma A/S to CiVi Biopharma ApS.
On October 17, 2025, CiVi Biopharma ApS entered liquidation.
On October 17, 2025, CiVi Biopharma ApS entered liquidation.
As of August 21, 2025, REVISIONSFIRMAET EDELBO & LUND-LARSEN, STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of CiVi Biopharma ApS.
As of August 21, 2025, Jess Thiersen has stepped down as liquidator of CiVi Biopharma ApS.
On August 21, 2025, CiVi Biopharma ApS exited liquidation.
As of October 22, 2024, REVISIONSFIRMAET EDELBO & LUND-LARSEN, STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of CiVi Biopharma ApS.
As of October 22, 2024, KPMG P/S has stepped down as auditor of CiVi Biopharma ApS.
As of September 4, 2024, Henrik Ørum has left the board of directors of CiVi Biopharma ApS.
As of September 4, 2024, Jess Thiersen is registered as liquidator of CiVi Biopharma ApS.
As of September 4, 2024, Martin Lavesen has stepped down as chairman of CiVi Biopharma ApS.
As of September 4, 2024, Jess Thiersen has stepped down as vice chairman of CiVi Biopharma ApS.
As of September 4, 2024, Henrik Ørum has stepped down as adm. dir. of CiVi Biopharma ApS.
On September 4, 2024, CiVi Biopharma ApS entered liquidation.
CiVi Biopharma ApS has published its annual report for 2023. Gross profit came to DKK 3,502,137, and the net result was DKK -1,887,334.
CiVi Biopharma ApS has published its annual report for 2022. Gross profit came to DKK 3,530,115, and the net result was DKK 326,318.
CiVi Biopharma ApS has published its annual report for 2021. Gross profit came to DKK 4,035,566, and the net result was DKK 344,004.
CiVi Biopharma ApS has published its annual report for 2020. Gross profit came to DKK 4,484,621, and the net result was DKK 391,972.
CiVi Biopharma ApS has published its annual report for 2019. Gross profit came to DKK 7,236,687, and the net result was DKK 648,729.
CiVi Biopharma ApS has published its annual report for 2018. Gross profit came to DKK 6,038,811, and the net result was DKK 706,732.
CiVi Biopharma ApS has published its interim report for the period September 20, 2016 – December 31, 2017.
As of January 17, 2017, KPMG P/S has been appointed auditor of CiVi Biopharma ApS.
As of January 17, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of CiVi Biopharma ApS.
As of September 20, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of CiVi Biopharma ApS.
As of September 20, 2016, Henrik Ørum has joined the board of directors of CiVi Biopharma ApS.
As of September 20, 2016, Martin Lavesen is registered as chairman of CiVi Biopharma ApS.
As of September 20, 2016, Jess Thiersen is registered as vice chairman of CiVi Biopharma ApS.
As of September 20, 2016, Henrik Ørum is registered as adm. dir. of CiVi Biopharma ApS.
CiVi Biopharma ApS was founded on September 20, 2016.
Companies in the same industry and area
CVR 29418888
CVR 29769796
CVR 34688605
CVR 26392861
CVR 41366044
